Incidence and survival patterns of cutaneous T-cell lymphomas in the United States

被引:104
作者
Imam, Muhammad Hassaan [1 ]
Shenoy, Pareen J. [2 ]
Flowers, Christopher R. [2 ]
Phillips, Adrienne [3 ]
Lechowicz, Mary Jo [2 ]
机构
[1] Emory Univ, Dept Internal Med, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA
[3] Columbia Univ, Dept Med Hematol Oncol, New York, NY USA
关键词
Cutaneous T-cell lymphoma; incidence; treatment outcome; racial disparities; MYCOSIS-FUNGOIDES; EUROPEAN-ORGANIZATION; SEZARY-SYNDROME; EORTC CLASSIFICATION; RACIAL-DIFFERENCES; TASK-FORCE; CANCER; LEUKEMIA; EPIDEMIOLOGY; SUBTYPES;
D O I
10.3109/10428194.2012.729831
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Using the United States Surveillance, Epidemiology and End Results (SEER) 17 dataset, we examined incidence and survival patterns for patients with cutaneous T-cell lymphomas (CTCLs) diagnosed following institution of the World Health Organization-European Organisation for Research and Treatment of Cancer (WHO-EORTC) classification. From 2005 to 2008, 2273 cases of CTCL were diagnosed. The age-adjusted incidence rate per 100 000 person-years for mycosis fungoides (MF) was 0.55 and for Sezary syndrome (SS) was 0.01. Incidence was higher among males (MF/SS male-to-female incidence rate ratio [IRR] 1.57) and black patients (MF black-to-white IRR 1.55). Black patients with CTCL were diagnosed at a younger age and black patients with MF/SS presented with advanced stage and had worse survival than white patients. In multiple-variable Cox-regression models, age >60 (hazard ratio [HR] 4.78, 95% confidence interval [CI] 2.97-7.70), black race (HR 2.09, 95% CI 1.29-3.37) and advanced stage (HR 6.06, 95% CI 3.66-10.05) predicted worse survival for patients with MF/SS. Additional research identifying reasons for these differences are necessary to better understand these diseases and for new strategies in the treatment of CTCL.
引用
收藏
页码:752 / 759
页数:8
相关论文
共 48 条
[11]   Incidence of cutaneous T-Cell lymphoma in the United States, 1973-2002 [J].
Criscione, Vincent D. ;
Weinstock, Martin A. .
ARCHIVES OF DERMATOLOGY, 2007, 143 (07) :854-859
[12]   Assessment of delayed reporting of mycosis fungoides and Sezary syndrome in the United States [J].
Dores, Graca M. ;
Curtis, Rochelle E. ;
Anderson, William F. ;
Demierre, Marie-France .
ARCHIVES OF DERMATOLOGY, 2008, 144 (03) :413-414
[13]  
Flowers Christopher R, 2007, Curr Probl Cancer, V31, P182, DOI 10.1016/j.currproblcancer.2007.01.005
[14]  
Flowers CR, 2012, LEUK LYMPHOMA
[15]   HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I TAX/REX DNA AND RNA IN CUTANEOUS T-CELL LYMPHOMA [J].
GHOSH, SK ;
ABRAMS, JT ;
TERUNUMA, H ;
VONDERHEID, EC ;
DEFREITAS, E .
BLOOD, 1994, 84 (08) :2663-2671
[16]   SKIN-CANCER IN BLACKS IN THE UNITED-STATES [J].
HALDER, RM ;
BANG, KM .
DERMATOLOGIC CLINICS, 1988, 6 (03) :397-405
[17]  
Hankey BF, 1999, CANCER EPIDEM BIOMAR, V8, P1117
[18]   Cutaneous T-cell lymphoma in skin of color [J].
Hinds, Ginette A. ;
Heald, Peter .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) :359-375
[19]  
Jaffe ES, 1999, AM J CLIN PATHOL, V111, pS8
[20]  
Kempf W, 2008, ARCH DERMATOL, V144, P1609, DOI 10.1001/archdermatol.2008.46